000 01344 a2200397 4500
005 20250511231818.0
264 0 _c19910129
008 199101s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1990.427
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMulder, N H
245 0 0 _aDacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.
_h[electronic resource]
260 _bBritish journal of cancer
_cDec 1990
300 _a1006-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aDacarbazine
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aRecombinant Proteins
700 1 _aWillemse, P H
700 1 _aSchraffordt Koops, H
700 1 _ade Vries, E G
700 1 _aSleijfer, D T
773 0 _tBritish journal of cancer
_gvol. 62
_gno. 6
_gp. 1006-7
856 4 0 _uhttps://doi.org/10.1038/bjc.1990.427
_zAvailable from publisher's website
999 _c2263290
_d2263290